[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[2]
|
Han, B., Zheng, R., Zeng, H., et al. (2024) Cancer Incidence and Mortality in China, 2022. Journal of the National Cancer Center, 4, 47-53. https://doi.org/10.1016/j.jncc.2024.01.006
|
[3]
|
Johnson, P.J., Berhane, S., Kagebayashi, C., et al. (2015) Assessment of Liver Function in Patients with Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade. Journal of Clinical Oncology, 33, 550-558. https://doi.org/10.1200/JCO.2014.57.9151
|
[4]
|
Maluccio, M. and Covey, A. (2012) Recent Progress in Understanding, Diagnosing, and Treating Hepatocellular Carcinoma. CA: A Cancer Journal for Clinicians, 62, 394-399. https://doi.org/10.3322/caac.21161
|
[5]
|
Reig, M., Forner, A., Rimola, J., et al. (2022) BCLC Strategy for Prognosis Prediction and Treatment Recommendation: The 2022 Update. Journal of Hepatology, 76, 681-693. https://doi.org/10.1016/j.jhep.2021.11.018
|
[6]
|
Ma, X.L., Zhou, J.Y., Gao, X.H., et al. (2016) Application of the Albumin-Bilirubin Grade for Predicting Prognosis after Curative Resection of Patients with Early-Stage Hepatocellular Carcinoma. Clinica Chimica Acta, 462, 15-22. https://doi.org/10.1016/j.cca.2016.08.005
|
[7]
|
Amisaki, M., Uchinaka, E., Morimoto, M., et al. (2018) Post-Operative Albumin-Bilirubin Grade Predicts Long-Term Outcomes among Child-Pugh Grade Patients with Hepatocellular Carcinoma after Curative Resection. Hepatobiliary & Pancreatic Diseases International, 17, 502-509. https://doi.org/10.1016/j.hbpd.2018.07.011
|
[8]
|
Wang, Y.Y., Zhong, J.H., Su, Z.Y., et al. (2016) Albumin–Bilirubin versus Child-Pugh Score as a Predictor of Outcome after Liver Resection for Hepatocellular Carcinoma. British Journal of Surgery, 103, 725-734. https://doi.org/10.1002/bjs.10095
|
[9]
|
Cho, W.R., Hung, C.H., Chen, C.H., et al. (2020) Ability of the Post-Operative ALBI Grade to Predict the Outcomes of Hepatocellular Carcinoma after Curative Surgery. Scientific Reports, 10, Article No. 7290. https://doi.org/10.1038/s41598-020-64354-0
|
[10]
|
詹一, 倪才方, 仲斌演, 等. ALBI分级在肝细胞癌肝功能评估及预后分层的应用及研究进展[J]. 实用医学杂志, 2023, 39(3): 381-385.
|
[11]
|
Ho, S.Y., Liu, P.H., Hsu, C.Y., et al. (2018) Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation. Scientific Reports, 8, Article No. 843. https://doi.org/10.1038/s41598-018-19251-y
|
[12]
|
Oh, I.S., Sinn, D.H., Kang, T.W., et al. (2017) Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Digestive Diseases and Sciences, 62, 3235-3242. https://doi.org/10.1007/s10620-017-4775-8
|
[13]
|
Kao, W.Y., Su, C.W., Chiou, Y.Y., et al. (2017) Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation. Radiology, 285, 670-680. https://doi.org/10.1148/radiol.2017162382
|
[14]
|
王哲轩, 王恩鑫, 夏冬东, 等. Child-Pugh评分和ALBI分级预测经肝动脉化疗栓塞治疗不可切除肝细胞癌预后的价值比较[J]. 临床肝胆病杂志, 2020, 36(1): 113-117.
|
[15]
|
Ho, S.Y., Liu, P.H., Hsu, C.Y., et al. (2017) Prognostic Role of Noninvasive Liver Reserve Markers in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. PLOS ONE, 12, e0180408. https://doi.org/10.1371/journal.pone.0180408
|
[16]
|
Zhao, S., Zhang, T., Li, H., et al. (2020) Comparison of Albumin-Bilirubin Grade versus Child-Pugh Score in Predicting the Outcome of Transarterial Chemoembolization for Hepatocellular Carcinoma Using Time-Dependent ROC. Annals of Translational Medicine, 8, Article 538. https://doi.org/10.21037/atm.2020.02.124
|
[17]
|
Kornberg, A., Witt, U., Schernhammer, M., et al. (2019) the Role of Preoperative Albumin-Bilirubin Grade for Oncological Risk Stratification in Liver Transplant Patients with Hepatocellular Carcinoma. Journal of Surgical Oncology, 120, 1126-1136. https://doi.org/10.1002/jso.25721
|
[18]
|
张瑜, 张珏, 刘现忠, 等. ALBI分级和NLR对HBV相关肝细胞癌患者肝移植预后的影响[J]. 临床肿瘤学杂志, 2021, 26(1): 55-60.
|
[19]
|
Pinato, D.J., Kaneko, T., Saeed, A., et al. (2020) Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade. Cancers, 17, Article 1862. https://doi.org/10.3390/cancers12071862
|
[20]
|
Campani, C., Bamba-Funck, J., Campion, B., et al. (2023) Baseline ALBI Score and Early Variation of Serum AFP Predicts Outcomes in Patients with HCC Treated by Atezolizumab-Bevacizumab. Liver International, 43, 708-717. https://doi.org/10.1111/liv.15487
|
[21]
|
Ueshima, K., Nishida, N., Hagiwara, S., et al. (2019) Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study. Cancers, 11, Article 952. https://doi.org/10.3390/cancers11070952
|
[22]
|
Vogel, A., Frenette, C., Sung, M., et al. (2021) Baseline Liver Function and Subsequent Outcomes in the Phase 3 REFLECT Study of Patients with Unresectable Hepatocellular Carcinoma. Liver Cancer, 10, 510-521. https://doi.org/10.1159/000516490
|
[23]
|
Hiraoka, A., Michitaka, K., Kumada, T., et al. (2017) Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function. Liver Cancer, 6, 325-336. https://doi.org/10.1159/000479984
|
[24]
|
Hiraoka, A., Kumada, T., Michitaka, K., et al. (2016) Usefulness of Albumin-Bilirubin Grade for Evaluation of Prognosis of 2584 Japanese Patients with Hepatocellular Carcinoma. Journal of Gastroenterology and Hepatology, 31, 1031-1036. https://doi.org/10.1111/jgh.13250
|
[25]
|
Müller, L., Hahn, F., Mähringer-Kunz, A., et al. (2021) Refining Prognosis in Chemoembolization for Hepatocellular Carcinoma: Immunonutrition and Liver Function. Cancers, 13, Article 3961. https://doi.org/10.3390/cancers13163961
|
[26]
|
Kariyama, K., Nouso, K., Hiraoka, A., et al. (2020) EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis. Liver Cancer, 9, 734-743. https://doi.org/10.1159/000508971
|